Moreover, chromatin immunoprecipitation sequencing (ChIP-Seq) identified fibroblast growth factor 14 (FGF14) as the downstream target of ZNF750, and blocking FGF14 reversed the tumor repressor effect of ZNF750 in NPC cells. This evidence concerns the gene FGF14 and nasopharyngeal carcinoma.